Note we may have some server downtime today and this weekend as we perform some upgrades. Please save a copy of any posts you make during this time in case we have any server trouble. Thank you!

Dr Zang

A board to discuss Tcelna as a treatment for Multiple Sclerosis

Dr Zang

Postby bromley » Thu May 24, 2007 2:34 pm

I think this article is about the Dr Zang who developed the T cell vaccination. Interesting that GSK have snapped him up - they are one of the big players.

GlaxoSmithKline Launches Chinese R&D Centre with Appointment of Head in Shanghai 24 May 2007

Jingwu Zang to lead work on neurogenerative diseases.


GlaxoSmithKline (GSK) today announced the appointment of Jingwu Zang to head a new GSK research and development centre in Shanghai, China. His appointment, as Senior Vice President, will be effective in June.

GSK R&D China will focus on research into neurodegeneration with the objective of creating new medicines for such severe disorders as multiple sclerosis, Parkinson’s disease, and Alzheimer’s disease. The centre will eventually direct the global discovery and development activities within its therapeutic area, from drug-target identification to late-stage clinical studies, while collaborating with research institutions elsewhere in China and other countries.

Dr. Zang, a neurologist and researcher in immunological and neurodegenerative disorders, will lead the scientific activities of the centre and the hiring of staff, which will begin immediately. It is anticipated that over the next decade GSK R&D China will grow to become one of the larger R&D facilities within GSK. Dr. Zang will report directly to Moncef Slaoui, Chairman, GSK R&D.

Dr. Slaoui commented: “We are entering an exciting period of expansion for our R&D organisation as it builds on the strength of the superb science now being conducted in China. We intend to be part of a future in which the phrase ‘discovered in China’ is heard as often as ‘made in China’ is heard today.

“Our initiative in China reflects our commitment to ally GSK with talented researchers wherever we can find them and to further encourage within R&D the contest of ideas needed to create new medicines. It shows as well our commitment to the neurosciences, where many of the greatest challenges in drug discovery and development are to be found. Indeed, as we create a centre in China to focus on neurodegenerative disorders, we will re-focus our largely UK-based neurology drug-discovery efforts on finding new therapies for pain, epilepsy, and brain injury.”

Until his appointment at GSK, Dr. Zang served most recently as the founding director and a professor at the Institute of Health Sciences in Shanghai. The Institute is an affiliate of the Chinese Academy of Sciences and the Shanghai Jiao Tong University School of Medicine. Under Dr. Zang’s direction, the Institute grew to comprise a staff of 150 and a cadre of graduate students numbering about 250 while broadening its mission to bridge the basic sciences and translational medicine.

Dr. Zang also served as research director of the Baylor Multiple Sclerosis Centre, Houston, Texas, where he concentrated on clinical research in multiple sclerosis and neuroimmunology.

Dr. Zang earned an M.D. degree at the Shanghai Second Medical University(now Shanghai Jiao Tong) and a Ph.D. degree in immunology at the University of Brussels, where he started his research into multiple sclerosis. He went on to complete postdoctoral training at Harvard Medical School and a clinical residency at Baylor College of Medicine. Dr. Zang has been Professor of Neurology at Baylor and held positions at the Chinese Academy of Sciences and Shanghai Jiao Tong. He is licensed in both Texas and Shanghai and has more than 20 years of experience in translational research. He is an author on more than 100 scientific papers, review articles, and book chapters.

“Dr. Zang brings to his role at GSK both an understanding of the biomedical research community in China and international experience as a scientist and clinician,” said Dr. Slaoui. “He has, moreover, demonstrated his capacity to assemble the talent required to make a success of a new R&D initiative.”

GlaxoSmithKline in China

The heritage of GlaxoSmithKline in China dates from 1908. GSK has its Chinese headquarters in Shanghai and major offices in Beijing, Tianjin, and Hong Kong. The company employs more than 2,200 people in China, and pursues all its businesses there: prescription medicines, vaccines, and over-the-counter medicines. It has manufacturing plants in Shanghai, Tianjin and Suzhou.

GSK also has a growing R&D presence in China. For the past decade, GSK has collaborated in discovery with the combinatorial Chemistry Laboratory at the Shanghai Institute of Materia Medica, the drug research institute of the Chinese Academy of Sciences. In development, GSK started 17 clinical studies in China during 2006 and plans an additional 18 in 2007.

Source: Pharma Live © 2007 Engel Publishing Partners (24/05/07)
User avatar
bromley
Family Elder
 
Posts: 1887
Joined: Fri Sep 10, 2004 3:00 pm

Re: Dr Zang

Postby Lyon » Thu May 24, 2007 3:44 pm

bromley wrote:I think this article is about the Dr Zang who developed the T cell vaccination. Interesting that GSK have snapped him up - they are one of the big players.
Good find Ian! I think you're right.

Not intended as a negative comment but for some reason I find it a little surprising that he allowed himself to be snapped up by GSK.

Bob
Lyon
Family Elder
 
Posts: 6063
Joined: Wed May 03, 2006 3:00 pm

Postby IHaveMS-com » Thu May 24, 2007 5:09 pm

This is Dr. Zhang who created Tovaxin. For almost 2 years, Dr. Zhang has split his duties between the Institute of Health Sciences in Shanghai and Baylor School of Medicine. The change he is making in China is from an academic position to a commercial position.

The T-cell vaccine process that he developed is licensed to Opexa by Baylor School of Medicine. I make that comment only so that no one will worry that this could somehow impact the current trials.
Best regards, Tim

In 2001, my family helped fund the startup of Opexa. My father served on the Board of Directors of PharmaFrontiers, now Opexa Therapeutics, until the company completed a successful 23-million dollar financing round.
User avatar
IHaveMS-com
Family Elder
 
Posts: 213
Joined: Tue Jun 07, 2005 3:00 pm

Postby JanethePain » Thu Jun 14, 2007 10:08 am

IHaveMS-com wrote:This is Dr. Zhang who created Tovaxin. For almost 2 years, Dr. Zhang has split his duties between the Institute of Health Sciences in Shanghai and Baylor School of Medicine. The change he is making in China is from an academic position to a commercial position.

The T-cell vaccine process that he developed is licensed to Opexa by Baylor School of Medicine. I make that comment only so that no one will worry that this could somehow impact the current trials.


The Nobel Committee really needs to honor this fine man with its highest award, in my not-so-humble opinion.
Jane the Pain
User avatar
JanethePain
Family Elder
 
Posts: 223
Joined: Wed Jun 13, 2007 3:00 pm
Location: Historical Glendale, OH: Home of the Squirrrels

Postby IHaveMS-com » Thu Jun 14, 2007 11:03 am

Hi Jane,

I can tell you are thrilled with your Tovaxin experience thus far, but hold off on booking your ticket to Stockholm for now.
Best regards, Tim

In 2001, my family helped fund the startup of Opexa. My father served on the Board of Directors of PharmaFrontiers, now Opexa Therapeutics, until the company completed a successful 23-million dollar financing round.
User avatar
IHaveMS-com
Family Elder
 
Posts: 213
Joined: Tue Jun 07, 2005 3:00 pm

Postby sh8un » Thu Jun 14, 2007 7:40 pm

Hi there
Are you the same Jane that was vaccinated in the very first trials in the 90's?
NN
sh8un
Family Elder
 
Posts: 303
Joined: Wed May 03, 2006 3:00 pm
Location: Calgary, AB, Canada

Postby sh8un » Thu Jun 14, 2007 8:05 pm

Hi Jane
never mind...Ijust read your other posts...you are not the same Jane...thanx for sharing though. I am very happy about your results.
sh8un
Family Elder
 
Posts: 303
Joined: Wed May 03, 2006 3:00 pm
Location: Calgary, AB, Canada


Return to Tcelna (Tovaxin)

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service